| KEGG Pathway Terms | Gene Count | % | P-value | Benjamini |
| Diabetes | ||||
| Type II diabetes mellitus | 12 | 0.1 | 3.6 x 10-4 | 9.8 x 10-3 |
| Cardiovascular Disease | ||||
| Vascular smooth muscle contraction | 18 | 0.1 | 1.6 x 10-3 | 3.6 x 10-2 |
| Arrhythmogenic right ventricular cardiomyopathy (ARVC) | 13 | 0.1 | 4.0 x 10-3 | 7.1 x 10-2 |
| Dilated cardiomyopathy | 14 | 0.1 | 7.6 x 10-3 | 1.2 x 10-1 |
| Neuron Function | ||||
| Long-term potentiation | 11 | 0.1 | 1.5 x 10-2 | 1.4 x 10-1 |
| Signaling | ||||
| MAPK signaling pathway | 35 | 0.2 | 2.4 x 10-4 | 9.9 x 10-3 |
| Calcium signaling pathway | 22 | 0.1 | 1.2 x 10-2 | 1.4 x 10-1 |
| Chemokine signaling pathway | 21 | 0.1 | 1.2 x 10-2 | 1.3 x 10-1 |
| Cancer | ||||
| Pathways in cancer | 42 | 0.3 | 4.1 x 10-5 | 3.4 x 10-3 |
| Glioma | 15 | 0.1 | 4.4 x 10-5 | 2.4 x 10-3 |
| Non-small cell lung cancer | 10 | 0.1 | 7.9 x 10-3 | 1.1 x 10-1 |
| Colorectal cancer | 13 | 0.1 | 8.4 x 10-3 | 1.1 x 10-1 |
| Chronic myeloid leukemia | 12 | 0.1 | 1.2 x 10-2 | 1.3 x 10-1 |